ADIPOQ and diabetes mellitus: Based on ROC analysis, the combined use of serum adiponectin and TNF-α R2 resulted in a significant enhancement of diabetes prediction by this clinical prediction model, with the enhancement being comparable to that provided by 2-hour plasma glucose, as assessed with a 75 g OGTT.